Prescient Healthcare Acquires Dolon to Expand Value, Pricing and Market Access Capabilities

April 1, 2026

Prescient Healthcare Group acquired Dolon, a London-based consultancy specializing in strategic pricing and market access for biopharma companies, to strengthen its drug lifecycle support capabilities. Dolon will continue operating as a dedicated Value, Pricing and Access practice within Prescient, enhancing integrated lifecycle insights including pricing, reimbursement, and market access decisions.

Buyers
Prescient Healthcare Group
Targets
Dolon
Sellers
Dolon and its shareholders
Location
United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.